Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heartbeam, Inc. - Common Stock
(NQ:
BEAT
)
1.960
-0.040 (-2.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Heartbeam, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
March 14, 2024
From
HeartBeam, Inc.
Via
Business Wire
What's Going On With Heartbeam (BEAT) Stock?
March 12, 2024
Heartbeam shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The company last week said it secured two new patents.
Via
Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Awarded Two New US Patents Covering Core Cardiac Monitoring Technology
March 07, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Thursday's Intraday Session
March 07, 2024
Via
Benzinga
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
March 07, 2024
From
HeartBeam, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 06, 2024
Via
Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q4 and FY 2023 Results Call
March 05, 2024
Via
Investor Brand Network
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
March 05, 2024
From
HeartBeam, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 21, 2023
Via
Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Combines AI, Proprietary Technology to Deliver Unprecedented Cardiac Insights
December 14, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
December 14, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q3 2023 Financial Report, Operational Update
November 15, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
HeartBeam Reports Third Quarter 2023 Financial Results
November 14, 2023
From
HeartBeam, Inc.
Via
Business Wire
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
November 13, 2023
The "Diya Jalao Roshni Lao" campaign was initiated by the Beat of Life Entertainment company in 2022. Its aim is to draw people's attention to our culture, the hard work of potters, hope, their lives,...
Via
IssueWire
Topics
Religion
Exposures
Religion
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Scientific Advisory Board as It Advances Product Development, Clinical and Commercial Efforts
November 09, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
HeartBeam Announces Expansion of Its Scientific Advisory Board
November 09, 2023
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
November 07, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Third Quarter 2023 Results Conference Call
October 31, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time
October 31, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Leaders to New Senior Management Positions
September 26, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team
September 26, 2023
From
HeartBeam, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
September 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 31, 2023
Via
Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2023 Financial Report, Corporate Update
August 11, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
HeartBeam Reports Second Quarter 2023 Financial Results
August 10, 2023
From
HeartBeam, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.